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The aim of this study was to evaluate the ResScreen® microbiological system for 26 
the identification of antibiotic residues in milk. This microbiological system consists of two 27 
methods, the "BT" (betalactams and tetracyclines) and "BS" (betalactams and sulfamides) 28 
bioassays, containing spores of G. stearothermophilus subsp. calidolactis, culture media 29 
and indicators (acid-base and redox). The detection limits of 29 antimicrobial agents were 30 
calculated using a logistic regression model.  31 
Both methods detect residues of penicillin-G, ampicillin, amoxicillin, cloxacillin, 32 
oxacillin, cephalexin, cefoperazone and ceftiofur® at levels close to their Maximum 33 
Residue Limits (MRL). The "BT" bioassay also presents good sensitivity to tetracycline 34 
and oxytetracycline residues, whereas the "BS" bioassay detects sulfadiazine, 35 
sulfamethoxazole and sulfathiazole residues in milk.  36 
The simultaneous use of both bioassays identifies betalactam, tetracycline and 37 
sulfamide residues in milk. Neomycin, tylosin and lincomycin residues can also be 38 
detected, but these molecules are positive with the “BT” and “BS” bioassays, e.g., 39 
betalactams, given the microorganisms’ sensitivity to these molecules. 40 
Key words: screening test, microbiological inhibition system, betalactams, tetracyclines, 41 








The presence of certain antibiotic residues in milk is a potential risk for consumers 49 
because they may be toxic and dangerous for human health, and may potentially cause 50 
antimicrobial resistance(1-2) and technological problems during dairy product manufacturing 51 
(3-5). 52 
For this purpose, several commercially available tests have been developed for the 53 
swift, precise detection of the presence of antibiotic residues in milk (6-7). Many screening 54 
tests are based on the inhibition of microorganism growth by the presence of drug residues. 55 
Among the most widely used microorganisms, we find Geobacillus stearothermophilus 56 
subsp. calidolactis in the following tests: Delvotest(8), BRT AiM(9), Eclipse(10) and 57 
Charm AIM-96(11). 58 
These methods can nonspecifically detect the “presence” or “absence” of antibiotic 59 
residues in milk. To identify β-lactam or sulfonamide compounds however, “positive” and 60 
“doubtful” samples are tested using penicillinase and p-aminobenzoic acid (PABA) 61 
solutions. Thus, antibiotic residues can be classified into betalactam antibiotics or 62 
sulfamides(12). 63 
However, the penicillinase and PABA methods do not suffice to identify other 64 
antimicrobial agents such as tetracyclines. So, when Yamaki et al.(13) investigated 2686 65 
samples of ewe’s milk, 47 samples were found to be positive with the Delvotest "SP" test. 66 
When using penicillinase and PABA methods, only 29.8% of the samples were identified 67 
as containing betalactam residues, while the remaining milk samples (70.2%) remained 68 
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unidentified. These authors suggested that this methodology is insufficient for a complete 69 
identification of milk antibiotic residues. 70 
In order to identify a higher number of antibiotic groups, Althaus and Nagel(14) 71 
proposed to use a microbiological system which not only complies with the International 72 
Standardization Organization guidelines(15), but also identifies betalactam, tetracycline and 73 
sulfonamide residues. 74 
This microbiological system consists of two methods, the "BT" (betalactams and 75 
tetracyclines) and "BS" (betalactams and sulfamides) bioassays, containing spores of G. 76 
stearothermophilus subsp. calidolactis, culture media and indicators (acid-base and redox). 77 
Moreover, this system includes synergistic components that improve the sensitivity of 78 
tetracycline (16) and sulfamide (17) residues in milk. 79 
Thus, the objective of this research was to evaluate the ResScreen® system for the 80 
identification of antimicrobial agent residues in milk by means of studying detection limits. 81 
 82 
MATERIALS AND METHODS 83 
 84 
Animals and milk samples  85 
The animals came from cattle herds of Las Colonias (Santa Fe, Argentina). For this 86 
study, milk samples corresponding to the morning machine milking session (6 am) of 16 87 
cows were collected in the 60-90 day postpartum period. The animals received no 88 
pharmacological treatment throughout the sampling period(18). 89 
The chemical composition and pH values of the selected samples were normal for 90 
bovine milk, with low somatic cell counts (SCC < 400000 cells ml-1) and an acceptable 91 
bacterial count for cow’s milk (CFU < 100000 cfu ml-1). 92 
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 93 
Antimicrobial solutions and spiked samples  94 
The drugs used for the preparation of antimicrobial solutions were stored and 95 
handled according to the manufacturers' instructions before use. All the dilutions were 96 
prepared in 100 ml volumetric flasks at the time the analyses were carried out in order to 97 
avoid the possibility of unstable solutions.  98 
Antimicrobial solutions were prepared using antimicrobial-free milk(18), as 99 
determined by the Delvotest®. The final drug concentrations in milk (g l-1) were achieved 100 
after serial dilutions so that the volume of the antimicrobial agent solution did not exceed 1 101 
% of the volume of the final solution to be analyzed(18). 102 
 103 
ResScreen® test  104 
The system consists of two microbial bioassays using Geobacillus 105 
stearothermophilus subsp. calidolactis C-953 spores. The microbiological method is based 106 
on growth inhibition of bacteria-test when milk containing residues of antibiotics.  107 
The BT bioassay (Betalactams and Tetracyclines) is composed of a culture medium 108 
containing spores of thermophilic microorganism, chloramphenicol and bromocresol purple 109 
indicator(16). If the milk sample is free of antibiotics and allows bacteria-test growth and 110 
changes in color of the acid base indicator (purple to yellow). Otherwise the test will 111 
remain the same color.  112 
Moreover, the BS bioassay (Beta-lactams and Sulfonamides) use a medium 113 
inoculated with a microorganism spore suspension, brilliant black indicator, toluidine blue 114 
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and trimethoprim(17). So, the absence of antibiotic residues in milk causes bacteria-test 115 
growth, producing a color change of indicators from black to amber. 116 
The ResScreen® system was carried out according to the manufacturer’s 117 
instructions. Thus, 50 l milk sample was added to individual plates of the “BT” and “BS” 118 
ResScreen® methods. Plates were incubated in a water bath at 641 ºC for 3 (“BT” 119 
ResScreen®) and 4 hours (“BS” ResScreen®) until the color change of the negative samples 120 
had taken place. 121 
Visual interpretation was performed independently by 3 trained persons, and was 122 
assessed visually as “negative” and “positive”; “doubtful” qualifications were interpreted as 123 
positive(19). 124 
 125 
Detection limits and cross specificity 126 
Detection limits: The following substances (Sigma Chemical Co, St. Louis, MO) were used 127 
to determine the ResScreen® system detection limits:  128 
- Ten betalactams: amoxicillin, ampicillin, cloxacillin, oxacillin, penicillin “G”, cefadroxil, 129 
cephalexin, cefoperazone, cefuroxime and ceftiofur®. 130 
- Four sulfonamides: sulfadiazine, sulfadimethoxine, sulfamethoxazole and sulfathiazole.  131 
- Three tetracyclines: chlortetracycline, oxytetracycline and tetracycline.  132 
The detection limits of the antimicrobial agents were established according to the 133 
Codex Alimentarius guidelines(18). For this purpose, 12 concentrations were prepared with 134 
different levels of each drug. For each concentration, 16 replicates were prepared using 135 
antibiotic-free milk samples. 136 
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Cross specificity: The Codex Alimentarius guidelines(18) were used to calculate the 137 
detection limits of the following antibiotics (Sigma Chemical Co, St. Louis, MO): 138 
- Four aminoglycosides: gentamycin, kanamycin, neomycin and streptomycin. 139 
- Four macrolides: erythromycin, lincomycin, tylosin and spiramycin. 140 
- Four quinolones: ciprofloxacin, norfloxacin, enrofloxacin and marbofloxacin. 141 
 142 
Statistical analysis 143 
The results were obtained by following the SAS® Logistic procedure(20). A logistic 144 
regression model was also done to calculate the detection limits, as follows: 145 
     Lij = logit [Pij] = 0 + 1 [A]i + ij 146 
 where: Lij = lineal logistic model; [Pij] = logit [Pp/(1-Pp)]: the probability of “positive” 147 
response / probability of “negative” response); 0, 1 = coefficients estimated for the logistic 148 
regression models; [A]i = antimicrobial concentration. ij = residual error. The concordance 149 
coefficient(20) was applied as the rank correlation between the observed responses and the 150 
predicted probabilities. 151 
The detection limit of the visual interpretation of the ResScreen® system was 152 
estimated as the concentrations at which 95 % of the results were assessed as “positive” or 153 
“doubtful”(19,21). 154 
 155 
RESULTS AND DISCUSSION 156 
Detection limits 157 
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The results of applying the logistic regression model to the positive relative 158 
frequency of the “BT” and “BS” ResScreen® system for the different antimicrobial agents 159 
assayed are shown in Table 1. 160 
The concordance coefficients obtained by applying the logistic model were high, 161 
between 89.2 % for oxytetracycline (“BT” ResScreen®) and 99.4 % for tetracycline (“BS” 162 
ResScreen®), demonstrating the correct adjustment achieved by the logistic model. 163 
The "1" coefficient represents the sensitivity of G. stearothermophilus to the 164 
antibiotics studied. This parameter reached higher values for penicillin antibiotics 165 
(amoxicillin, ampicillin, cloxacillin, oxacillin and penicillin "G") than for the rest of the 166 
antimicrobial agents assayed, demonstrating the sensitivity of G. stearothermophilus to 167 
detect the residues of these antimicrobials.  168 
The "1" coefficients values of cephalosporins (cefadroxil, cephalexin, 169 
cefoperazone, ceftiofur® and cefuroxime) were similar to those calculated for tetracyclines 170 
(“BT” ResScreen®) and sulfamides (“BS” ResScreen®). In contrast, the "1" parameter of 171 
tetracyclines (“BS” ResScreen®) and sulfonamides (“BT” ResScreen®) were very low, 172 
showing low sensitivity for detection purposes. 173 
Figures 1 and 2 show the effect of penicillin and cephalosporin concentrations on 174 
the visual interpretations of the ResScreen® system, as well as the curves constructed by the 175 
logistic model (“0“ and “1“ coefficients, Table 1). The concentrations of ampicillin, 176 
amoxicillin, oxacillin and penicillin "G" (high “1“ coefficient values) underwent a slight 177 
increase to produce 100 % positive results, whereas the concentrations of cephalosporins 178 
(Figure 2) had to undergo greater increments to obtain positive results in both methods 179 
(lower “1“ coefficient values). 180 
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The dose-response curves for tetracyclines (“BT” ResScreen®, Figure 3) and 181 
sulfonamides (“BS” ResScreen®, Figure 4) showed adequate sensitivity to detect the 182 
residues belonging to both antibiotic groups. Conversely, high concentrations of 183 
tetracyclines (“BS” ResScreen®, Figure 3) and sulfonamides (“BT” ResScreen®, Figure 4) 184 
were needed given the low “1“ coefficients values (Table 1). 185 
The detection limits of the ResScreen® system calculated by means of logistic 186 
regression models for betalactams, tetracyclines and sulfonamides are shown in Table 2. 187 
Amoxycillin, ampicillin, cloxacillin, oxacillin, penicillin “G”, cephalexin, 188 
cefoperazone and ceftiofur® showed similar detection limits (Table 2) for the ResScreen® 189 
system to their respective Maximum Residue Limits (MRLs). 190 
For betalactam antibiotics, other microbiological methods such as BRT® AiM(22-23), 191 
Charm®(24), Delvotest® “SP”(22, 25) , Eclipse® 100ov(26) have similar detection limits to the 192 
ResScreen® system. 193 
With regard to tetracyclines, Table 2 indicates how the “BT” ResScreen® method 194 
presented detection limits near at the MRLs, unlike the “BS” method which required higher 195 
concentrations of these antibiotics for them to be detected. 196 
The detection limits calculated for the three tetracyclines with the “BT” ResScreen® 197 
method were lower than those reported by other authors with the BRT® AiM(22-23), Charm® 198 
AIM-96(24), Delvotest® “SP”(22,25) and Eclipse® 100ov(26) methods due to improved 199 
sensitivity from adding chloramphenicol to the culture medium(16). 200 
Also, Table 2 indicates how the detection limits of sulfonamides for “BS” 201 
ResScreen® approached their MRLs, while the “BT” method was not sensitive enough to 202 
detect these drugs in milk (detection limits higher than 12000 µg l-1).  203 
 10
The “BS” ResScreen® method detection limits of sulfonamides were slightly higher 204 
than those observed for BRT® AiM(27), although other authors have reported higher 205 
detection limits for BRT® AiM(22-23), Delvotest® “SP”(22,25) and Eclipse® 100(26). 206 
 207 
Cross specificity 208 
The detection limits calculated by the logistic model for other antimicrobial agents 209 
(aminoglycosides, macrolides and quinolones) with the ResScreen® system are provided in 210 
Table 3. Of all these antibiotics, only neomycin, lincomycin and tylosin residues were 211 
detected by the ResScreen® system at levels approaching their MRLs.  212 
Various authors have indicated similar detection limits to those calculated in Table 213 
3 by other methods using G. stearothermophilus subsp. calidolactis, such as BRT® AIM(22-214 
23), Charm® AIM-96(24) and Delvotest® “SP”(22,25) indicating good sensitivity to these three 215 
antibiotics (neomycin, lincomycin, tylosin) and a low detection capacity for the rest of 216 
antimicrobials. 217 
 218 
Identification of antibiotic residues by the ResScreen® system 219 
Table 4 summarizes the results of Table 2 and Table 3 by collectively and simply 220 
presenting the interpretation of the results of both bioassays. 221 
Milk samples that led to changes in color of both bioassays indicate the absence of 222 
antimicrobials (or substances that were not detected by this system). Beta-lactam antibiotics 223 
were identified by the persistence of both methods’ original colors. The fact that the 224 
original color of the “BT” bioassay remained and the original color of the “BS” bioassay 225 
changed denotes the presence of tetracycline residues. Conversely, milk samples that have 226 
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sulfamides brought about a change in the color of the “BT” method but maintained the 227 
color of the “BS” method.   228 
Finally, those milk samples containing neomycin, lincomycin or tylosin residues 229 
were detected by the ResScreen® system, but were identified as beta-lactams because the 230 
"BT" and "BS" bioassays were sensitive enough to detect such substances (Table 3). The 231 
difficulty owing to the cross specificity of the ResScreen® system could be resolved by 232 




To summarize, the ResScreen® system uses only two bioassays and provides a 237 
simple, economical solution to identify residues in milk. Moreover, this microbiological 238 
system identifies a larger number of antibiotic families (beta-lactams, tetracyclines and 239 
sulfamides) compared with current penicillinase and p-aminobenzoic acid methodologies 240 
(beta-lactams and sulfamides).  241 
In the future, new bioassays can be incorporated into the ResScreen® system in 242 
order to increase its identification capacity to other antibiotic groups (macrolides, 243 
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Table 1. Summary of the logistic regression model parameters of antibiotics in milk for the 332 
ResScreen® system  333 
 334 
Antibiotics 
ResScreen® “BT ResScreen® “BS” 
Logit = β0 + β1*[A] C Logit = β0 + β1*[A] C 
Betalactams       
Amoxycillin Logit = -11.3966 + 1.5185*[A] 96.7 Logit = -15.8159 + 3.7160*[A] 97.7 
Ampicillin Logit = -14.7862 + 2.3659*[A] 98.5 Logit = -21.6358 + 6.8009*[A] 99.1 
Cloxacillin Logit = -13.1755 + 0.3835*[A] 97.9 Logit = -10.9673 + 0.3371*[A] 97.5 
Oxacillin Logit = -18.4151 + 1.2483*[A] 98.6 Logit = -22.3155 + 1.5409*[A] 98.9 
Penicillin “G” Logit = -16.1514 + 6.1636*[A] 98.9 Logit = -22.5024 + 8.1827*[A] 99.4 
Cefadroxil Logit = -7.9435 + 0.0683*[A] 95.7 Logit = -16.0260 + 0.0970*[A] 97.5 
Cephalexin Logit = -10.0512 + 0.1313*[A] 97.4 Logit = -9.9664 + 0.0767*[A] 97.0 
Cefoperazone Logit = -11.0985 + 0.2277*[A] 98.3 Logit = -12.6755 + 0.1669*[A] 97.9 
Ceftiofur Logit = -12.1451+ 0.1438*[A] 98.8 Logit = -6.7069 + 0.0841*[A] 94.3 
Cefuroxime Logit = -13.07 + 0.3282*[A] 98.9 Logit = -20.0044 + 0.1321*[A] 99.6 
Tetracyclines       
Clortetracycline Logit = -9.4066+ 0.0556*[A] 90.7 Logit = -10.1408 + 0.0036*[A] 97.7 
Oxytetracycline Logit = -10.8242 + 0.0933*[A] 89.2 Logit = -9.9616 + 0.0153*[A] 97.0 
Tetracycline Logit = -9.0156 + 0.0627*[A] 89.8 Logit = -26.5938 + 0.0309*[A] 99.4 
Sulfonamides       
Sulfadiazine Logit =  -8.2241 + 0.0002*[A] 95.0 Logit = -22.089+ 0.1525*[A] 91.0 
Sulfadimethoxine Logit = -18.8281 + 0.0018*[A] 98.7 Logit = -11.9029 + 0.0577*[A] 90.0 
Sulfamethoxazole Logit = -16.7196 + 0.0015*[A] 97.9 Logit = -11.0868 + 0.1167*[A] 89.3 
Sulfathiazole Logit = -20.2747 + 0.0017*[A] 98.6 Logit = -9.0399 + 0.1246*[A] 89.3 
0, 1 = coefficients estimated for the logistic regression models; [A]: antimicrobial concentrations; C: 335 
concordance coefficients. 336 
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Table 2. The ResScreen system detection limits (g l-1) for antibiotics in milk  337 
 338 
a MRLs (g l-1), EU maximum residue limits, * : Decision limits in ewe  milk. 339 
340 
Antibiotics 
ResScreen® BRT® AIM Delvotest®SP Charm® AIM Eclipse® 100ov
MRLsa
BT BS 
Charm y Ruth 
(1993)(22) 
Heeschen et al. 
(1995)(23) 
Charm y Ruth 
(1993)(22) 
Althaus et al. 
(2002)(25)* 
Linage et al 
(2007)(24)* 
Montero et al. 
(2005)(26)* 
Beta-lactams          
Amoxycillin 8 5 5 --- 10 5 --- 7 4 
Ampicillin 7 4 10 5 10 3 6 --- 4 
Cloxacillin 42 40 100 35 50 23 42 68 30 
Oxacillin 17 16 --- --- --- --- --- 28 30 
Penicillin “G” 3 3 10 1.5 2.5 1.4 4 5 4 
Cefadroxil 159 190 --- --- --- 63 --- 86 --- 
Cephalexin 99 160 --- --- --- 68 202 115 100 
Cefoperazone 62 94 --- --- --- 41 82 110 50 
Ceftiofur 105 115 100 --- 50 59 107 --- 100 
Cefuroxime 42 170 --- --- --- 41 --- 85 --- 
Tetracyclines          
Clortetracycline 275 3600 >1000 --- 420 --- 3989 1500 100 
Oxytetracycline 150 850 1000 --- 200 420 501 560 100 
Tetracycline 158 720 1000 450 420 450 257 480 100 
Sulfonamides          
Sulfadiazine 49000 164 1000 100-1000 >1000 260 --- --- 100 
Sulfadimethoxine 12000 260 100 100-1000 >1000 --- 119 170 100 
Sulfamethoxazole 14000 120 --- --- --- 110 --- --- 100 
Sulfathiazole 13000 100 1000 100-1000 >1000 --- 151 250 100 
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Table 3. The ResScreen system detection limits (µg l-1) for other antimicrobials in milk 341 
 342 
a MRLs (g l-1), EU maximum residue limits, * : Decision limits in ewe  milk.343 
Other 
antimicrobials 
ResScreen® BRT® AIM Delvotest®SP Charm® AIM Eclipse® 100ov
MRLsa
BT BS 
Charm y Ruth 
(1993)(22) 
Heeschen et al. 
(1995)(23) 
Charm y Ruth 
(1993)(22) 
Althaus et al. 
(2002)(25)* 




Aminoglycosides          
Gentamycin 320 530 >500 --- 150 1200 382 3140 100 
Kanamycin 5600 6200 --- --- --- --- --- 18700 150 
Neomycin 600 1200 >500 300 150 3300 1084 9100 1500 
Streptomycin 2300 3600 >1000 --- >1000 10000 3593 10100 200 
Macrolides          
Erythromycin 210 190 1000 2250 400 980 522 750 40 
Lincomycin 150 220 --- --- --- --- --- --- 150 
Tylosin 74 50 50 --- 100 120 51 230 50 
Spiramycin 3400 2600 --- --- --- --- 1346 18100 200 
Quinolones          
Ciprofloxacin 1750 1710 --- --- --- --- --- 5100 100 
Enrofloxacin 2000 2300 --- --- --- --- 46000 4000 100 
Marbofloxacin 2700 4400 --- --- --- --- --- --- 75 
Norfloxacin 7100 6800 --- --- --- --- --- 9500 --- 
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ResScreen® “BT” ResScreen® “BS” 
Absence (or not detect) - - 
Betalactams   +(*) +(*) 
Tetracyclines + - 
Sulfamides - + 
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Fig. 1 Dose-response curves for different penicillin concentrations in milk analyzed by the Rescreen® system (▲: 348 
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 351 
Fig. 2 Dose-response curves for different cephalosporin concentrations in milk analyzed by the Rescreen® system (▲: 352 
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Fig. 3 Dose-response curves for different tetracycline concentrations in milk analyzed by the Rescreen® system (▲: chlortetracyline, 356 
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 359 
Fig. 4 Dose-response curves for different sulphamide concentrations in milk analyzed by the Rescreen® system (■: 360 
sulfadiazine, ▲: sulfadimethoxine, ♦: sulfamethazine, ●: sulfamethoxazole, Χ: sulfatiazole). 361 
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